Objectives: To systematically analyse the interplay between the expression of Hfq-associated small non-coding RNAs (sRNAs) and antibiotic susceptibility in Gram-negative bacteria.
Introduction
The inappropriate use of antibiotics has induced the generation of a whole population of MDR bacteria or 'superbugs' as they are commonly described. 1 -3 In addition, the mistreatment of patients with inappropriate antibiotics, coupled with insufficient knowledge of the origin of infection, has cast a shadow over the antibiotic medical miracle. To aid the fight against superbugs, it is important to understand the mechanisms by which bacteria acquire antibiotic resistance under stress conditions.
To date, .100 small non-coding RNAs (sRNAs), which are modulators of various biological events, have been identified in Escherichia coli. 4 -9 Many of these have been studied extensively and were shown to regulate mRNAs via imperfect base-pairing interactions. 4 -9 The Hfq protein facilitates binding of these trans-acting sRNAs to their target mRNAs. 10 -13 Hfq has attracted considerable attention because it plays critical roles in sRNAmediated cellular pathways in multiple types of bacteria. In E. coli, Hfq mediates drug resistance by regulating the efflux system 14 and is required for the regulation of inter-kingdom signalling and virulence. 15 The Salmonella Hfq homologue is an important virulence factor and was investigated as a live oral vaccine in a murine model of typhoid fever. 16 Moreover, Hfq is a master regulator of biofilm formation by Salmonella. 17 Hfq in Listeria monocytogenes facilitates stress tolerance and contributes to pathogenesis in mice. 18 Based on the involvement of Hfq in antimicrobial-related activities such as virulence and biofilm formation, its associated sRNAs are also likely to be responsive modulators of antibiotic susceptibility. In support of this theory, several lines of investigation showed that the expression of Hfq-binding sRNAs and their cognate target genes correlates with bacterial susceptibility to an antibiotic challenge. 19 -23 For instance, the expression of sRNAs MicF and MicC, which target the major porins OmpF and OmpC, respectively, modulates the outer membrane's fluidity and permeability to antibiotics. 24 -26 Additionally, the overexpression of DsrA was found to induce multidrug resistance in E. coli via the MdtEF efflux pump. 27 More recently, RyhB sRNA was reported to regulate susceptibility to colicin 20 and the induction of RyeB (SdsR) was shown to be required for ampicillininduced mutagenesis via its interaction with a specific target, the mutS gene. 21 These findings clearly suggest that Hfq-binding sRNAs may play multiple roles in antibiotic resistance by altering metabolic pathways in response to a single cue. However, the functional roles of sRNAs as part of the intrinsic responses of bacteria to specific antibiotic challenges through the modulation of unique sRNA-mediated cellular pathways, and the potential ways in which these pathways could be exploited to control and detect MDR bacteria, remain largely unknown. This is the first known systematic study to generate barcode signatures for all of the known 26 Hfq-binding sRNAs in E. coli challenged with multiple antibiotics. We used detailed knowledge of these barcode signatures to evaluate the essentiality of Hfq or sRNA expression and conservation of antibiotic susceptibility within other species of Gram-negative bacteria to potentiate the treatment and/or efficacy of existing and widely used antibiotics against Gram-negative MDR bacteria.
Materials and methods

Strains, plasmids and primers
The strains and plasmids used in this study are listed in Table S1 (available as Supplementary data at JAC Online). The pBRplac and 26 E. coli Hfq-dependent pBRplac-sRNA libraries 28 (Table S2) were a gift from Dr Susan Gottesman (Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA). The pBRplac-S-MicC was constructed by PCR amplification of micC from Salmonella strain 14028S using primers S-MicC_F/S-MicC_R. The PCR product was then cloned into the AatII and EcoRI sites in the pBRplac vector. All pBRplac-sRNA plasmids were confirmed by DNA sequencing before being transformed into the E. coli MG1655 or Salmonella 14028S strains. Overexpression of sRNAs from pBRplac-sRNA was achieved by adding 0.1 mM IPTG to the culture medium. The primers used in this study (purchased from NeoProbe, Korea) are listed in Table S3 . The MDR strains were purchased from the Culture Collection of Antimicrobial Resistant Microbes (CCARM; http://knrrb.knrrc.or.kr/index. jsp?rrb=ccarm). To confirm the Keio collection strains, 29 the selected sRNA target genes were amplified by PCR using specific primer sets, and the resulting products were sequenced using the same primer sets (Table S3) . The E. coli ArcZ, ChiX, CyaR, GcvB, IS118, MicA, MicC, MicF, OxyS, RprA, RseX, RybB, RybD, RydC, SgrS and Spot42 knockout mutants were generated as described in a previous report that documented the process used to generate the Keio collections, 29 using the specific primer sets listed in Table S3 . The RyeB knockout mutant was prepared by mutating the promoter region (210) of ryeB from TATTCT to CTCGAG using scarless mutagenesis 30 and then confirmed by DNA sequencing analysis. All sequencing analyses were performed by Solgent, Inc. (Korea).
Antimicrobials
Ampicillin (A1593, Sigma), apramycin (A2024, Sigma), cefixime (1097658, Fluka), cefotaxime (C2224, TCI), cefuroxime (C4417, Sigma), cefalotin (C4520, Sigma), gentamicin (G0383, TCI), kanamycin (B5264, Sigma), nalidixic acid (N5035, Sigma), levofloxacin (28266, Sigma), lomefloxacin (L2906, Sigma), meropenem (M2279, TCI), minocycline (M2288, TCI), neomycin (N6386, Sigma), norfloxacin (N0817, TCI) and streptomycin (S9137, Sigma) were purchased from the vendors indicated. Stock and working antimicrobial solutions used for MIC determinations were prepared according to the specific manufacturer's instructions.
Determination of the MIC
The MIC was determined by modification of the microbroth dilution 31 and Sensititre TM system MIC method, 32 with the concentration ranges given in the CLSI guidelines. 33 Briefly, pure colonies grown overnight on LB plates supplemented with or without antibiotics were used to prepare a bacterial suspension in nuclease-free water (71786, USB). This suspension was normalized to a 0.5 McFarland turbidity standard using a Sensititre TM Nephelometer (Trek Diagnostic systems) and a vortex mixer (VortexGenie 2, Scientific Industries, Inc.). A 10 mL aliquot was then transferred into a tube containing 10 mL of Sensititre TM Mueller -Hinton broth (MHB; 211443, BD) with TES buffer (Trek Diagnostic Systems), supplemented or not supplemented with IPTG (0.1 mM), and mixed on a vortex mixer (Vortex-Genie 2, Scientific Industries, Inc.) for 10 s. The cells (45 mL) in the tube were dispensed into 96-well microtitre plates (34296; SPL, Korea) containing the antimicrobial (5 mL of a 10-fold concentrated solution). After inoculation, the panel was covered with an adhesive clear plate seal (MM3619; Labogene) and incubated at 378C for 24 h. The MICs of the antimicrobials were determined by manually taking photographs of individual bacterial clots in 96-well plates using a Manual Viewer (Trek Diagnostic systems) and a Nikon 1 V1 camera. We defined cell growth as a visible clot in an individual well, regardless of its size. Therefore, the MICs determined using this method were more stringent than those determined using the Sensititre TM system, 32 which defines growth as the generation of a clot following antibiotic treatment that is similar in size to the clot generated in the absence of antibiotic. Therefore, most of the 2-fold changes in the MIC would probably be higher if they were determined using the Sensititre TM system. The determined MICs were reproducible in three experiments.
Growth curve analysis and determination of viable cell counts
Bacterial cells expressing the pBRplac or pBRplac-sRNA plasmids were normalized to a 0.5 McFarland turbidity standard using a Sensititre TM Nephelometer (Trek Diagnostic Systems) and a vortex mixer (VortexGenie 2, Scientific Industries, Inc.). The standardized cells were diluted (10 3 -fold) in MHB (BD, catalogue number 211443) and working solutions (95 mL of cells with 5 mL of water or 10-fold concentrated antibiotic solution) were dispensed into 96-well microplate wells. To prevent vaporization, 50 mL of mineral oil (M8410, Sigma-Aldrich) was added to each well and the plate was incubated at 378C for 16 h with idle movement. Growth was determined every 20 min by measuring the turbidity at 600 nm (OD 600 ) using a FLUOstar microplate reader (BMG Labtech), and the 1 h interval data were analysed using Omega V3.00R2 software (BMG Labtech). After growth for 16 h, aliquots of the cells cultivated with different concentrations of antibiotics were diluted to the same OD 600 value, deposited onto LB agar plates, which were incubated overnight at 378C. Images were then taken using the ChemiDoc TM MP System (Bio-Rad). All measurements and comparisons were performed in triplicate. The growth curve data were statistically analysed using JMP software (SAS Institute Inc.), and statistically significant data (P,0.05) were plotted as the mean+SD using SigmaPlot (v12.5) (Systat Software Inc.).
Analysis of the effects of RyeB on susceptibilities of MDR strains to antibiotics
The MICs of levofloxacin for the seven E. coli and three Salmonella strains (CCARM) were determined as described above. Because the MDR strains were resistant to ampicillin or tetracycline, we screened for laboratory vectors that enabled selection using different antibiotics. MDR strain transformants harbouring plasmid pUA66, 34 which has a similar copy number to that of pBRplac, were selectable on LB agar plates supplemented with 50 mg/L kanamycin and could be confirmed by colony PCR assays. To prepare the sRNA expression vectors (pUA-pBR and pUA-RyeB) used to transform MDR cells, fragments of the pBRplac or pBRplac-RyeB plasmid were amplified by PCR using the pUA_pBR_F/R primers (Table S3 ). These fragments, which included both the plac and sRNA sequences, were subcloned into pUA66 at the XhoI and BamHI linker sites. The resulting vectors (pUA-pBR and pUA-RyeB) were analysed by DNA sequencing using the pUA66_F primer (Table S3 ). The pUA-pBR and pUA-RyeB plasmids were introduced into MDR bacteria by electroporation, and successful transformation was confirmed by colony PCR using the pUA66_F and pUA66_R primers 34 (Table S3 ). To determine whether the RyeB-induced change in antimicrobial susceptibility was vector dependent, the pUA-pBR and pUA-RyeB vectors were also introduced into MG1655 cells. RyeB expression was induced by the addition of IPTG (0.1 mM). The MICs of antibiotics for MDR strains expressing pUA-pBR or pUA-RyeB were measured as described above. To determine the effects of overexpression of RyeB on the number of viable cells, fresh colonies of MDR strains expressing pUA-pBR or pUA-RyeB were used to prepare bacterial suspensions, which were normalized to a 0.5 McFarland turbidity standard. A 10 3 -fold dilution of the cells was inoculated into 1.5 mL of MHB supplemented with 0.1 mM IPTG and the indicated concentrations of levofloxacin, and the cells were grown at 378C for 16 h with shaking (220 rpm). Turbidity was determined by measuring the OD 600 using a FLUOstar microplate reader (BMG Labtech); the cells were then diluted 4×10
5 -fold and 100 mL aliquots were spread onto LB agar plates, which were incubated at 378C overnight. The number of colonies on the plates was counted and the relative viable cell count was defined as the total number of viable pUA-pBR-or pUA-RyeB-expressing MDR cells treated with levofloxacin divided by the number of viable MDR cells that were not treated with levofloxacin. All measurements and comparisons were performed in triplicate. Statistical analyses were performed using JMP software (SAS Institute Inc.), and statistically significant data (P, 0.05) were plotted as the mean+SD using SigmaPlot (v12.5) (Systat Software Inc.).
Screening of sRNA target genes for antibiotic susceptibility phenotypes
A 5×10 4 -fold dilution of an overnight culture of each Keio collection strain was inoculated into 150 mL of MHB containing sub-MICs or MICs of the selected antibiotics (norfloxacin, cefalotin, minocycline or cefuroxime for MicF; norfloxacin or levofloxacin for RyeB) and then dispensed into 96-well plates and cultured at 378C for 24 h. The growth phenotypes (survival or lethal) of the individual Keio collection strains at different concentrations of antibiotics were recorded manually and selected as hits when the phenotype was reproducible in all three experiments.
Quantitative RT-PCR (qRT-PCR)
To determine the transcript levels of predicted or target mRNAs, total RNA was extracted from bacterial cells using the RNeasy Mini Kit (Qiagen). Synthesis of cDNA and quantitative PCR was performed using the CFX Connect TM Real-Time PCR Detection System (Bio-Rad), as described in a previous report, 35 and the primers listed in Table S3 . Data analysis was performed using CFX Manager Software (v3.0), and statistically significant data (P, 0.05), analysed using JMP software (SAS Institute Inc.), were plotted as the mean+SD of n ¼ 3 replicates using SigmaPlot (v12.5) (Systat Software Inc.).
Northern blot analysis
Strains cultured overnight were diluted (1 : 100) with fresh LB supplemented or not supplemented with ampicillin (100 mg/L) and grown at 378C.
Total RNA was extracted using TRIzol w (Life Technologies) during the exponential growth phase (OD 600 ¼1.0) for sRNA-overexpressing strains or during the stationary growth phase (OD 600 ¼3.0) for sRNA knockout strains. Then, 3 mg aliquots of individual samples were fractionated on 5% polyacrylamide gel (+7 M urea) and electrotransferred onto a Hybond TM -N+ membrane (GE Healthcare) using a TE77 Semi-dry transfer unit (GE Healthcare) at 185 mA for 45 min. The membrane was hybridized with 5 ′ biotinylated oligonucleotides (Table S3) with Rapid-Hyb buffer (GE Healthcare) at 428C. Expression of sRNAs was detected using the Brightstar Biodetect Kit (Ambion) following the manufacturer's instructions. Hybridization signals were analysed using the ChemiDoc TM MP System (Bio-Rad).
Results and discussion
Screening for Hfq-binding sRNAs that modulate susceptibility to antibiotics A library of plasmids that express each of the 26 Hfq-dependent sRNAs in E. coli was developed, and overexpression to saturate sRNA levels within a cell was used to elucidate the roles of sRNAs in important physiological mechanisms in bacteria. 28 We adapted this technique to define the identities of specific antibiotics modulated by individual sRNAs in E. coli: 26 Hfq-dependent E. coli sRNAs were individually overexpressed from pBRplac vectorbased libraries, 28 and susceptibility of the cells to 14 antibiotics from five widely used subclasses was determined. Based on MICs, overexpression of 17 of the 26 sRNAs reproducibly conferred resistance (R), susceptibility (S) or a mixture of R and S on specific antibiotics (Table S4 and Figure S1 ). Among them, nine sRNAs (ChiX, CyaR, MicC, MicF, OxyS, RseX, RybD, RyeB and SgrS) showed solely R or S phenotypes to 11 antibiotics (Table 1) , while eight sRNAs (ArcZ, GcvB, IS118, MicA, RprA, RybB, RydC and Spot42) showed mixed phenotypes (Table S4 and Figure S1 ). These results were confirmed by determining the effects of antibiotics on the R and S strains using bacterial growth curve and cell viability analyses ( Figures S2 and S3 ). To our knowledge, these results represent the first barcode signatures for most of the well-known Hfq-binding sRNAs in E. coli in terms of the effectiveness of antibiotics. These barcodes enable us to show the relationship between sRNA expression and the bacteria's response to an antibiotic through cellular pathways specific to each sRNA, which may have been identified or remains to be elucidated.
Genetic requirement for sRNA expression in antibiotic susceptibility
We hypothesized that if susceptibility of E. coli to antibiotics does depend on the expression of target sRNAs, as identified by barcode signatures, phenotypes of strains created by sRNA overexpression would be reversed by sRNA suppression. To test this hypothesis, 17 E. coli sRNA knockout strains were generated, and the MICs of the 11 or 12 antibiotics whose efficacies were affected by overexpression of these sRNAs were determined (Tables 1 and S4 ). Depletion of 13 sRNAs (ArcZ, ChiX, CyaR, GcvB, IS118, MicA, MicC, OxyS, RprA, RybD, RseX, SgrS and Spot42) did not reverse the susceptibility of E. coli cells to the antibiotics, suggesting that these sRNAs are sufficient but not necessary for the antibiotic susceptibility phenotype. Because individual sRNAs are induced by unique environmental cues, and because their actions are regulated under such conditions, 6 we do not exclude the possibility that Impact of Hfq-binding sRNAs on antimicrobial susceptibility 
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specific stress conditions are required for sRNA-mediated antimicrobial phenotypes. By contrast, depletion of MicF, RybB or RydC partially reversed the R or S phenotype induced by overexpression of the sRNA. In particular, the requirement of MicF for resistance to norfloxacin is consistent with the findings of a previous report showing that the knockout of micF led to a slight alteration in growth. 22 However, to the best of our knowledge, this study is the first to report the requirement of MicF for resistance to cephalosporins. Meanwhile, the depletion of RyeB completely reversed the S phenotype to all target antibiotics induced by overexpression of the sRNA, suggesting that RyeB's effect on antibiotic susceptibility is much stronger than that shown by the previous single finding that induction of RyeB is required for ampicillin-induced mutagenesis. 21 
Requirement of Hfq protein for sRNA function on antibiotic susceptibility
In subsequent analyses, we focused on the nine R-and S-associated sRNAs. Recently, the Hfq protein, acting alone, was found to be involved in the multidrug resistance mechanisms of E. coli and Salmonella enterica serovar Typhimurium. 14, 36 Therefore, individual sRNA-induced modulation of antibiotic susceptibility may require the Hfq protein for the complete phenotype. To determine whether the presence of hfq is required to alter antibiotic susceptibility via sRNAs, nine R-or S-specific sRNAs were overexpressed into the hfq mutant strain of E. coli. Interestingly, we found that the hfq mutation produced three different types of susceptibility. First, the resistant or susceptible phenotypes generated by overexpression of six individual sRNAs (ChiX, CyaR, MicC, RybD, RyeB and SgrS) to all tested antibiotics were completely nullified in the hfq mutant strain (Table 1) . This indicates that the Hfq protein is necessary for such sRNA-mediated antibiotic-resistant phenotypes. Second, the sRNA-induced phenotype varied with the antibiotic applied to hfq -cells. For instance, MicF overexpression in hfq -cells induced the resistance phenotype in response to cefotaxime and cefalotin, whereas MicF overexpression nullified the resistance phenotype in response to cefuroxime, norfloxacin or minocycline. Third, the phenotype induced by OxyS or RseX overexpression was retained in the absence of hfq. Interestingly, the MIC values of target antibiotics for strains expressing these sRNAs were much higher (4-to 8-fold) than in the background strain (hfq+ cells). The above data indicate that the Hfq protein is not the sole component modulating OxyS, RseX or MicF sRNA-mediated antibiotic susceptibility, raising the possibility that not Hfq protein but individual sRNAs alone are the factors that determine antibiotic susceptibility to cefalotin and/or cefotaxime via modulation of uncharacterized gene(s) or with the aid of other factor(s).
Conservation of sRNA-mediated antibiotic susceptibility from E. coli to Salmonella
The sequences and functions of Hfq-binding sRNAs are conserved in many bacteria; 37,38 therefore, we hypothesized that the Impact of Hfq-binding sRNAs on antimicrobial susceptibility 1663 JAC sRNA-induced R and S phenotypes observed in E. coli would be conserved across Gram-negative species closely related to E. coli. Homology searches of R and S sRNAs in various enterobacteria showed that, with the exception of RybD, homologues of the remaining eight E. coli R and S sRNAs were generally distributed among Gram-negative species, and their sequences were highly similar to those in E. coli ( Figure S4 ). Among them, Salmonella was selected as a target bacterium to test our hypothesis because its Hfq protein is involved in multidrug resistance; 36 therefore, we expected that the antimicrobial phenotypes of such Hfq-binding sRNAs would be similarly modulated in Salmonella if the sRNAs target the same gene(s).
To test this hypothesis, all nine E. coli sRNAs were expressed from the pBRplac vector (which did not perturb the screening conditions used for E. coli) and introduced into Salmonella cells; MIC levels were then determined (Table 1 and Figure S5 ) and growth curve analyses ( Figure S6 ) and cell viability assays ( Figure S7 ) were performed. With the exception of RybD, all of the E. coli sRNAs modulated the antimicrobial susceptibility of Salmonella in a manner identical to that observed in E. coli, indicating that the effects of sRNA by itself on the antibiotic phenotypes are conserved between E. coli and Salmonella. In an opposite direction, we also evaluated the effect of the Salmonella-derived sRNA on antibiotic susceptibility. Because the induced level of E. coli MicC showed increased susceptibility to a single antibiotic, nalidixic acid, in a conserved manner (Table 1) , we selected Salmonella MicC as a representative sRNA for this purpose, introduced the expression platform into both E. coli and Salmonella, determined MIC values and performed growth curve analyses. As shown in Figures S8 and S9 , the induced level of Salmonella MicC from pBRplac-S-MicC showed the same susceptible phenotype to nalidixic acid in both E. coli and Salmonella. Therefore, we expect that Gram-negative species harbouring one of our screened sRNAs may control the expression of the same antimicrobial target gene(s), resulting in the same antibiotic susceptibility phenotypes.
Identification of sRNA-modulated genes affecting antibiotic susceptibility sRNAs target multiple mRNAs involved in specific pathways; 4 -10 therefore, we sought to identify sRNA-affected antimicrobial (Table S8 ) was determined as the concentration at which no clot was formed and is indicated by a black circle.
target pathways or genes. We focused on MicF and RyeB because these sRNAs were required for the antimicrobial phenotypes against multiple antibiotics (Table 1) . Therefore, we suspect that MicF and RyeB target and modulate multiple genes when faced with an antibiotic challenge. Current strategies for identifying sRNA targets involve bioinformatic predictions, followed by experimental validation. Several tools for sRNA target prediction, each with their own merits and limitations, are available; hence, combinatorial information needs to be considered. Using the recently updated TargetRNA2 and CopraRNA databases, 39, 40 100 genes, including known targets such as E. coli ompF 41 and lrp, 42 were preselected as candidate targets of MicF (Table S5) or RyeB (Table S6) . We further added the known target genes phoE 42 and mutS 21 to the list. Assuming that target genes are down-regulated completely by sRNAs, the available 89 or 93 E. coli gene knockout strains from the preselected candidate targets were used to screen for phenotypes similar to those induced by overexpression of MicF or RyeB. The knockout of 18 and 5 genes, respectively (indicated in Figure S10 ), reproducibly resulted in a phenotype comparable to that of E. coli overexpressing MicF and RyeB, respectively, for at least one of the antibiotics tested (data not shown). Among them, known target genes for MicF, such as lrp, ompF and phoE, were listed as hits. Very recently, mutS, a recently discovered E. coli gene whose stability is regulated by RyeB, was identified as a probable modulator of the mechanism responsible for RpoS-dependent ampicillin-induced mutagenesis. 21 However, introduction of a knockout mutS gene did not alter susceptibility to our tested antibiotics, although its transcript level was 2-fold decreased by RyeB overexpression (data not shown).
Our phenotypic analyses were based on the endpoint of stationary cell growth; however, it is important to consider whether the regulation of target gene expression varies with growth stage. Therefore, further determination of gene expression levels was made by qRT -PCR in E. coli cells overexpressing MicF or RyeB at exponential and stationary growth phases (Figure 1b and d) . Genes negatively regulated by .30% in comparison with control cells, in either growth phase, were selected as the final target genes (Table S7 ). The expression levels of the three known gene targets (lrp, ompF and phoE), as well as those of the three predicted targets (cptA, hsdS and zwf), were reproducibly decreased by overexpression of MicF in either growth phase (Figures 1b and  S10 ). However, qRT -PCR analyses revealed that not all of these genes (hsdS and ompF being the exceptions) were up-regulated in a DmicF strain (Figure 1c ), suggesting that MicF is sufficient, but not necessary, for the regulation of these genes. The expression levels of the three predicted RyeB targets (dnaK, lpxL and tolC) were also decreased by overexpression of RyeB (Figure 1d) , and the level of tolC in particular was reduced by .75%. Underlining on the models indicates genes whose expression levels were down-regulated by sRNA overexpression and which conferred the change in antibiotic susceptibility in the relevant knockout strains. Transcription factors (SoxS, MarA or Rob) regulate micF or zwf expression. All information about gene function or regulatory pathways is adapted from EcoCyc (www.ecocyc.org). In the case of RyeB, we included the mutS gene in the model of RyeB-mediated antibiotic susceptibility because mutS is regulated by RyeB and is a plausible modulatory component in ampicillin susceptibility. 21 However, the mutS knockout strain did not have altered susceptibility to RyeB-mediated quinolone antibiotics in our experimental conditions. Impact of Hfq-binding sRNAs on antimicrobial susceptibility Furthermore, expression levels of lpxL and tolC were up-regulated in a DryeB strain (Figure 1e ), suggesting that RyeB is necessary for the regulation of these genes. To confirm the effects of knocking out the newly identified MicF and RyeB targets on antibiotic susceptibility, the MICs of cefalotin, cefuroxime, levofloxacin, minocycline and norfloxacin for the relevant E. coli gene knockout strains were determined (Table S8 and Figure 1f and g ). For MicF, generally a 2-to 4-fold increase in MIC of cefalotin for all target gene knockout strains except zwf was observed. However, the increase of MIC of such gene knockouts to cefuroxime, minocycline and norfloxacin was strongly gene dependent. For RyeB, the susceptible phenotypes of E. coli gene knockout strains of the RyeB target candidates (dnaK, lpxL or tolC) to norfloxacin and levofloxacin were the same. Overall, the experiments described above are the first to identify cellular pathways (mediated by MicF and RyeB), and their related genes, that determine susceptibility to antibiotics (Table S7 and Figure 2a and b) ; however, the pathways themselves remain to be characterized. Many of these genes have not been reported previously as components of sRNA regulation and/or antibiotic susceptibility change. Based on targeting of multiple genes by a single sRNA, we propose that bacteria use sRNAs to rapidly become tolerant to an antibiotic challenge; hence, using sRNAs to target antibiotic-susceptible genes could be an efficient, alternative therapeutic method of modulating bacterial resistance. Additional identification of the specific sRNAs modulating antibiotic susceptibility, accompanied by target identification, will reinforce this hypothesis.
RyeB as a potentiator of levofloxacin in modulating MDR isolates
RyeB promoted the susceptibility of E. coli to several quinolone antibiotics, including levofloxacin (Table 1) . To test the hypothesis that overexpression of RyeB in MDR bacteria would specifically increase their susceptibility to levofloxacin, we determined the MICs of levofloxacin for seven MDR E. coli strains showing variability in their susceptibility to quinolone antibiotics (Table S9) . Some of the MDR strains used in this study showed resistance to ampicillin and/or tetracycline (Table S9) , which are the resistance markers encoded by the pBRplac vector used to overexpress RyeB. Therefore, RyeB was cloned into the pUA66 plasmid, 34 which contains a kanamycin resistance gene, and overexpressed in MG1655 cells. The MICs of levofloxacin, nalidixic acid and norfloxacin for cells harbouring pUA-RyeB were comparable to those for cells harbouring pBRplac-RyeB (Table S10 ), indicating that the increased antibiotic susceptibility of the E. coli cells overexpressing RyeB from pBRplac-RyeB was not due to the use of ampicillin/tetracycline for selection. Overexpression of RyeB from pUA-RyeB rendered four of the seven MDR E. coli strains and two of the three MDR Salmonella strains susceptible to levofloxacin (Table S9 and Figure S11 ). The RyeB-induced reductions in the MICs of levofloxacin for these four E. coli strains were confirmed by cell viability assays (Figure 3 ). To determine whether the RyeB-induced reduction in the resistance to antibiotics is specific to levofloxacin, the effects of overexpression of RyeB on the susceptibilities of the six Figure 3 . Potentiation of the susceptibilities of MDR strains to levofloxacin by overexpression of RyeB. Cells were transformed with pUA66-derived vectors (pUA-pBR or pUA-RyeB) into CCARM strains. Relative viable cell counts (%) were analysed as described in the Materials and methods section. Data are represented as the mean+SD of n ¼ 3 replicates of statistically significant data (P, 0.05) for four CCARM E. coli strains showing drug resistance to multiple antibiotics (Table S9) MDR E. coli and Salmonella strains described above to unrelated or less effective antibiotics (cefalotin, cefixime, lomefloxacin and norfloxacin) were examined. The MICs of these antibiotics for the MDR strains were not affected by overexpression of RyeB (Table S11 ). These results suggest that RyeB could be a potentiator of levofloxacin for the treatment of resistant bacteria. Levofloxacin is an excellent quinolone antibiotic, used for the effective initial therapy of urinary tract infections; 43, 44 however, the prevalence of levofloxacin-resistant E. coli has been increasing worldwide recently. 45 Moreover, levofloxacin-resistant E. coli are more likely to be resistant to other antibiotics compared with levofloxacin-susceptible isolates. 46, 47 Therefore, this first known report of sRNA-mediated increases in the efficacy of levofloxacin might be useful in the bid to reduce the numbers of resistant E. coli.
